The invention discloses a cholelithiasis treatment drug, and belongs to the technical field of traditional Chinese medicines. The cholelithiasis treatment drug is prepared from three groups of bulk drugs, wherein the first group of the drugs comprises japanese climbing fern spore, cape jasmine, submature bitter orange, common burreed tuber, blue turmeric rhizome, rheum, christina loosestrife herb, amur corktree bark, Chinese thorowax root, salvia miltiorrhiza and chicken's gizzard-membrane, the second group of the drugs comprises Chinese thorowax root, christina loosestrife herb, amur corktree bark, white peony root, chicken's gizzard-membrane, silybum marianum, costusroot, corydalis tuber, salvia miltiorrhiza, tuckahoe, asiatic plantain seed, wenchow turmeric root tuber, Japanese climbing fern spore, submature bitter orange and cape jasmine, the third group of the drugs comprises Chinese thorowax root, salvia miltiorrhiza, finger citron fruit, noble dendrobium stem herb, baikal skullcap root, dangshen, tuckahoe, areca peel, common jujube, largehead atractylodes rhizome, milkvetch root, common yam rhizome, immature tangerine fruit, angelica, villous amonmum fruit, hawthorn and licorice root, the first group of the drug is continuously taken 10-20 days, the second group of the drug is continuously taken 10-20 days, and the third group of the drug is continuously taken 5-8 days. According to the present invention, cholelithiasis treatment is divided into three stages, an effective rate is 100%, and recurrence is not easily generated after disease treatment.